Citi lifts Novo Nordisk target on strong GLP-1 pill launch
Citi lifts Novo Nordisk target on strong GLP-1 pill launch Proactive uses images sourced from Shutterstock Citi has…
Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record
Novo Nordisk faces new GLP-1 rival as Eli Lilly’s triple agonist sets weight-loss record Proactive uses images sourced…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says Proactive uses…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says Proactive uses…
Novo Nordisk’s Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says
Novo Nordisk’s (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy continues to outpace its main competitor despite a slight weekly…
Novo Nordisk GLP-1 pill launch impresses but price erosion keeps Citi on the sidelines
Novo Nordisk GLP-1 pill launch impresses but price erosion keeps Citi on the sidelines Proactive uses images sourced…
Lilly’s FDA-approved oral weight-loss pill puts Novo Nordisk’s Wegovy franchise under fresh pressure
GLP-1 wars: Lilly’s FDA-approved oral weight-loss pill puts Novo Nordisk’s Wegovy franchise under fresh pressure Proactive uses images…
Novo Nordisk GLP-1 pipeline shows promise but oral drug trends give analysts pause
Novo Nordisk GLP-1 pipeline shows promise but oral drug trends give analysts pause Proactive uses images sourced from…
Novo Nordisk GLP-1 pipeline shows promise but oral drug trends give analysts pause
Novo Nordisk GLP-1 pipeline shows promise but oral drug trends give analysts pause Proactive uses images sourced from…
Citi appoints Fredrik Magnusson as Head of Nordics Commercial Banking
Stockholm, Sweden – Today, Citi appointed Fredrik Magnusson as Managing Director, Head of…
Novo Nordisk downgraded by leading banks as CagriSema trial flops against Zepbound
Novo Nordisk downgraded by leading banks as CagriSema trial flops against Zepbound Proactive uses images sourced from Shutterstock…
Novo Nordisk downgraded by leading banks as CagriSema trial flops against Zepbound
Novo Nordisk downgraded by leading banks as CagriSema trial flops against Zepbound Proactive uses images sourced from Shutterstock…